In the News
Cigna Invests In GNS Healthcare Precision Medicine Venture
Forbes contributor Bruce Japsen notes that the Cigna investment "fits the effort by health insurance companies to use claims data and related patient health information to better target illness and provide more cost-effective and high quality patient care. These...
read more
GNS Among Ways Amgen is Applying AI to Combat Serious Illness
Wired magazine dove in to a few approaches Amgen is taking to using AI to combat serious illness and one of those ways is by partnering with GNS! Amgen, the world's largest independent biotech company, is leading the charge in combining life sciences with data and...
read more
Iya Khalil weighs in on AI in Real-World Drug Discovery
Following the recent Bio-IT conference, Iya Khalil and fellow keynote panelists weigh in on how AI is impacting real-world drug discovery efforts. Read the full article here.
read moreEvents
GNS Hosts Webinar Discussing Causal AI for Inferring Patient Response
On November 12 GNS Healthcare scientists were joined by Dr. Alan Venook of UCLA and the Alliance for Clinical Trials in Oncology to discuss understanding what drugs work for whom in the context of colorectal cancer. To view the webinar recording or download the...
read more
Colin Hill Discusses AI and Machine Learning in Cancer Medicine at The Hill’s Future of Healthcare Summit
Colin Hill, CEO and Co-founder of GNS Healthcare, joined distinguished speakers at The Hill's inaugural Future of Healthcare Summit to discuss the impact of technology on the transformation of care. Panelists included: Justin Barad, Co-Founder and CEO, Osso VR Paul...
read more
Colin Hill Discusses AI and Machine Learning in Cancer Medicine at Milken Institute
Colin Hill, CEO and Co-founder of GNS Healthcare, joined distinguished speakers at the Milken Institute Global Conference to discuss the impact of AI and machine learning on cancer medicine, including: Mike Nohaile, Senior Vice President of Strategy, Commercialization...
read morePress Releases
GNS Healthcare Announces Strategic Investment from Merck Global Health Innovation Fund
Merck GHI joins leading biopharma companies Amgen, BMS, Zambon Pharmaceuticals, and leading health plans Cigna, Cambia Health Solutions, Echo Health Ventures, Horizon Blue Cross of NJ, and Heritage Provider Network, as an investor in GNS Healthcare. CAMBRIDGE, Mass. –...
read moreGNS Healthcare Raises $23 Million Led by Cigna Ventures
Cigna Ventures taps GNS’ technology and solutions to further advance whole person health for Cigna’s customers and clients Additional partners participating in recent funding round include Amgen Ventures, Celgene Corporation, Echo Health Ventures and Alexandria...
read moreGNS Healthcare Chosen to Present Discovery of New Clinical Predictors of Overall Survival in Metastatic Colorectal Cancer at ESMO 2019 in Collaboration with the Alliance for Clinical Trials in Oncology
AI-driven in silico patients used to identify heterogeneous landscape of clinical predictors of overall survival in populations of patients with metastatic colorectal cancer. CAMBRIDGE, Mass.– [July 2, 2019] – GNS Healthcare (GNS), a leading precision medicine...
read more